Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study
- 29 April 2006
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 25 (5), 310-317
- https://doi.org/10.1007/s10096-006-0133-z
Abstract
Determination of antibody levels against vaccine-preventable diseases is of great value to assess immunization programmes. The objective of this study was to determine the prevalence of measles, rubella, and mumps antibodies in representative samples of the child and adult population of Catalonia and compare the findings to those obtained in 1996. A representative sample of the child and adult (≥15 years) population of Catalonia was studied. Enzyme-linked immunosorbent assay techniques were used to determine the presence of antibodies. Equivocal results for antibodies against measles and rubella were tested using an immunofluorescence technique. To compare proportions, the chi-square test and the Fisher’s exact test were used. Statistical significance was set at 0.05. Adjusted odds ratios were calculated using multiple logistic regression analysis. Samples from 2,619 people were analyzed. The global prevalence of antibodies was 98.3% for measles, 91.1% for mumps, and 98.1% for rubella. The prevalence of rubella antibodies was higher in women than in men (98.8 vs. 97.2%, respectively). Compared with the results obtained in the 1996 seroprevalence study, only the prevalence of rubella antibodies showed a statistically significant increase in men (97.2 vs. 94.6%; p=0.002) and, in particular, in women (98.8 vs. 95.3%; p<0.001). The low prevalence of susceptible subjects has already led to the elimination of indigenous measles in Catalonia and should allow the elimination of indigenous rubella by 2005. The level of antibodies necessary to interrupt the transmission of mumps has still not been reached in all age groups.Keywords
This publication has 33 references indexed in Scilit:
- Etiology of Mumps‐Like Illnesses in Children and Adolescents Vaccinated for Measles, Mumps, and RubellaThe Journal of Infectious Diseases, 2005
- Sero-epidemiology of mumps in western EuropeEpidemiology and Infection, 2003
- Measles and Rubella in the World Health Organization European Region: Diversity Creates ChallengesThe Journal of Infectious Diseases, 2003
- Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination PolicyEpidemiologic Reviews, 2002
- Epidemiology of measles, mumps and rubella in ItalyEpidemiology and Infection, 2002
- Current Lessons from 20th Century Serosurveillance Data on RubellaClinical Infectious Diseases, 2001
- The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubellaEpidemiology and Infection, 2000
- ERADICATION OF VACCINE-PREVENTABLE DISEASESAnnual Review of Public Health, 1999
- Measles immunity and vaccination policy in CataloniaVaccine, 1999
- Mumps and rubella: a year of enhanced surveillance and laboratory testingEpidemiology and Infection, 1999